Ascletis Pharma Inc

Common Name
Ascletis Pharma
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
208
Ticker
1672
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Ascletis Pharma Inc. is a pioneering biopharmaceutical company based in China, primarily focused on the development of therapeutics aimed at addressing significant unmet medical needs in the infectiou...

Ascletis Pharma's Climate Target Data Preview

As of 2024, Ascletis Pharma has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Ascletis Pharma ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Intensity-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Other Intensity Metric (Unlisted)
Copy restricted. Please purchase to unlock this data.
a
2025
Download Ascletis Pharma's Climate Targets data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind Ascletis Pharma’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ascletis Pharma’s data sources below and access millions more through our Disclosure Search.

a. Ascletis Pharma's Annual Report 2024
Trace every data point back to Ascletis Pharma’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Ascletis Pharma's Greenhouse Gas Emissions Pathways

As of 2024, Ascletis Pharma has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions. a

Want Full Access to Ascletis Pharma's Climate Targets Dataset?
Sign Up